Imatinib mesylate minimally affects bcr-abl+ and normal monocyte-derived dendritic cells but strongly inhibits T cell expansion despite reciprocal dendritic cell-T cell activation.
May 2006 - J. Leukoc. Biol.; 79(4):0741-5400 [PMID:16461746]
[Boissel N] [Rousselot P] [Raffoux E] [Cayuela JM] [Soulier J] [Mooney N] [Charron D] [Dombret H] [Toubert A] [Rea D]